Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.2.1.51 - alpha-L-fucosidase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Adenocarcinoma
"In vitro" effect of progesterone on alpha-L-fucosidase activity of human endometrium.
Alteration in glycosidases from well-differentiated colorectal adenocarcinoma of rat.
Low levels of alpha-L-fucosidase activity in colorectal cancer are due to decreased amounts of the enzymatic protein and are related with Dukes' stage.
Adenoma
Spironolactone bodies in aldosteronomas and in the attached adrenals. Enzyme histochemical study of 19 cases of primary aldosteronism and a case of aldosteronism due to bilateral diffuse hyperplasia of the zona glomerulosa.
Alopecia
[Studies on enzyme activities in the hair root in male pattern baldness: glycolytic enzyme, acid hydrolase, transglutaminase and ornithine decarboxylase activities of plucked hair roots]
alpha-l-fucosidase deficiency
Absence of alpha-fucosidase activity in two sisters showing a different phenotype.
Acid hydrolase deficiencies and abnormal glycoproteins in mucolipidosis. 3 (pseudo-Hurler polydystrophy).
Characterization and 400-MHz 1H-NMR analysis of urinary fucosyl glycoasparagines in fucosidosis.
Correction of alpha-L-fucosidase deficiency in fucosidosis fibroblasts by retroviral vector-mediated gene transfer.
Fucosidosis type 2.
Fucosidosis with angiokeratoma. Immunohistochemical & electronmicroscopic study of a new case and literature review.
Histology and electron microscopy of fucosidosis of the skin. Subtle clues to diagnosis by electron microscopy.
Hydantoin-5-propionic aciduria in folic acid nondependent formiminoglutamic aciduria observed in two siblings.
Normal alpha-L-fucosidase and other lysosomal enzyme activities in progressive cone dystrophy.
Relationship between alpha-L-fucosidase deficiency in plasma and alpha-L-fucosidase activity in leukocytes.
Two different families with alpha-L-fucosidase deficiency.
Two patients with an unusual form of type II fucosidosis.
[Hepatic cholesterolosis. Histological, histochemical and ultrastructural study of 2 cases]
alpha-Mannosidosis
Chronic enzyme replacement therapy ameliorates neuropathology in alpha-mannosidosis mice.
Anemia, Sickle Cell
Genome-Wide Analysis Identifies IL-18 and FUCA2 as Novel Genes Associated with Diastolic Function in African Americans with Sickle Cell Disease.
Angiokeratoma
Angiocheratoma corporis diffusum with normal enzyme activities.
Fucosidosis type 2.
Fucosidosis.
Avitaminosis
[Possible participation of cyclic AMP in regulating acid hydrolase activity in muscle tissue in avitaminosis E and denervation]
Blister
Acid hydrolases in blister fluid. 6. Photocontact and contact allergic skin reactions.
Acid hydrolases in blister fluid. 7. Influence of dimethyl sulphoxide and heat.
Bone Resorption
Hormonal regulation of acid phosphatase release by osteoclasts disaggregated from neonatal rat bone.
Breast Neoplasms
Down-regulation of ?-L-fucosidase 1 expression confers inferior survival for triple-negative breast cancer patients by modulating the glycosylation status of the tumor cell surface.
Frequency of an allele for low activity of alpha-L-fucosidase in sera: possible increase in epithelial ovarian cancer patients.
Serum beta-N-acetylglucosaminidase, beta-D-glucosidase, alpha-D-glucosidase, beta-D-fucosidase, alpha-L-fucosidase and beta-D-galactosidase levels in acute viral hepatitis, pancreatitis, myocardial infarction and breast cancer.
Carcinogenesis
A novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cells.
FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status.
Carcinoma
A Meta-Analysis: Identification of Common Mir-145 Target Genes that have Similar Behavior in Different GEO Datasets.
Alpha-L-fucosidase-1 is a diagnostic marker that distinguishes mucoepidermoid carcinoma from squamous cell carcinoma.
Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma.
Ascites trophectodermal carcinoma cells exhibit embryonic mouse alpha-L-fucosidase isoenzyme pattern whereas the fluid exhibits adult mouse pattern.
Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
Isoelectric forms of alpha-L-fucosidase in mouse teratocarcinoma-derived cell lines.
Present and future possibilities for early diagnosis of hepatocellular carcinoma.
Serum alpha L-fucosidase enzyme activity in ovarian and other female genital tract tumors.
Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
Serum alpha-L-fucosidase. A useful marker in the diagnosis of hepatocellular carcinoma.
Serum alpha-L-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma?
Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
The Value of Preoperative Alpha-L-Fucosidase Levels in Evaluation of Malignancy and Differential Diagnosis of Urothelial Neoplasms.
[Diagnostic significance of the determination of serum alpha-L-fucosidase in primary hepatocellular carcinoma]
[Diagnostic value of serum alpha-L-fucosidase in primary hepatic carcinoma]
Carcinoma, Embryonal
Isoelectric focusing of alpha-L-fucosidase from human embryonal carcinoma.
Isoelectric forms of alpha-L-fucosidase in mouse teratocarcinoma-derived cell lines.
Carcinoma, Hepatocellular
Acid hydrolase activity during the induction and transplantation of hepatomas in the rat.
Activities of serum enzymes in patients with viral hepatitis B, posthepatitic cirrhosis and hepatocellular carcinoma.
Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study.
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks.
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
Alpha-L-fucosidase as a tumour marker of hepatocellular carcinoma.
Alpha-l-Fucosidase Immunoassay for Early Detection of Hepatocellular Carcinoma.
Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma.
Biochemical aspects of alpha-L-fucosidase in hepatocellular carcinoma.
Chromogenic immunodetection of human serum albumin and alpha-L-fucosidase clones in a human hepatoma cDNA expression library.
Diagnostic value of alpha-L-fucosidase for hepatocellular carcinoma: a meta-analysis.
Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
Evaluation of the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma.
Glycolipid composition of ascitic fluids from patients with cancer.
Glycosyltransferases and glycosidases in Morris hepatomas.
Molecular biology of the alpha-L-fucosidase gene and fucosidosis.
Molecular cloning of a cDNA for human alpha-L-fucosidase.
Origins and Evolution of the ?-L-Fucosidases: From Bacteria to Metazoans.
Prediction of the development of hepato-cellular-carcinoma in patients with liver cirrhosis by the serial determinations of serum alpha-L-fucosidase activity.
Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Serum AFU, 5'-NT and AFP as Biomarkers for Primary Hepatocellular Carcinoma Diagnosis.
Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
Serum alpha-L-fucosidase. A useful marker in the diagnosis of hepatocellular carcinoma.
Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma.
Serum midkine is a more sensitive predictor for hepatocellular carcinoma than Dickkopf-1 and alpha-L-fucosidase in cirrhotic HCV patients.
Study of the Alpha-l-Fucosidase Langmuir Monolayer at the Air-Water Interface.
The clinical significance of serum alpha-L-fucosidase assay in hepatocellular carcinoma.
[A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma]
[Diagnostic significance of the determination of serum alpha-L-fucosidase in primary hepatocellular carcinoma]
[Value of serum glycosidase spectrum in the diagnosis of hepatocellular carcinoma]
Carcinoma, Mucoepidermoid
Alpha-L-fucosidase-1 is a diagnostic marker that distinguishes mucoepidermoid carcinoma from squamous cell carcinoma.
Carcinoma, Ovarian Epithelial
Frequency of an allele for low activity of alpha-L-fucosidase in sera: possible increase in epithelial ovarian cancer patients.
Carcinoma, Squamous Cell
A Meta-Analysis: Identification of Common Mir-145 Target Genes that have Similar Behavior in Different GEO Datasets.
Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
Present and future possibilities for early diagnosis of hepatocellular carcinoma.
The Value of Preoperative Alpha-L-Fucosidase Levels in Evaluation of Malignancy and Differential Diagnosis of Urothelial Neoplasms.
Cataract
Acid phosphatase localization in the equatorial region of human lenses.
Central Nervous System Diseases
Recombinant canine alpha-l-fucosidase: expression, purification, and characterization.
Cholangiocarcinoma
Alpha-L-Fucosidase Serves as a Prognostic Indicator for Intrahepatic Cholangiocarcinoma and Inhibits Its Invasion Capacity.
Cholelithiasis
[Alpha-L-fucosidase activity in patients with ductal cholelithiasis]
Cholesterol Ester Storage Disease
[Hepatic cholesterolosis. Histological, histochemical and ultrastructural study of 2 cases]
Chronic Periodontitis
Relationship of subgingival plaque flora to lysosomal and cytoplasmic enzyme activity in gingival crevicular fluid.
Colonic Neoplasms
Activity and properties of alpha-L-fucosidase are dependent on the state of enterocytic differentiation of HT-29 colon cancer cells.
Colorectal Neoplasms
Alpha-L-fucosidase enzyme in the prediction of colorectal cancer patients at high risk of tumor recurrence.
Clinical interest of the combined use of serum CD26 and alpha-L-fucosidase in the early diagnosis of colorectal cancer.
Decreased Expression of Alpha-L-Fucosidase Gene FUCA1 in Human Colorectal Tumors.
Low levels of alpha-L-fucosidase activity in colorectal cancer are due to decreased amounts of the enzymatic protein and are related with Dukes' stage.
Preoperative AFU Is a Useful Serological Prognostic Predictor for Colorectal Liver Oligometastasis Patients Undergoing Hepatic Resection.
Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer.
Value of the serum alpha-L-fucosidase activity in the diagnosis of colorectal cancer.
Cone Dystrophy
Normal alpha-L-fucosidase and other lysosomal enzyme activities in progressive cone dystrophy.
Progressive cone dystrophy associated with low alpha-L-fucosidase activity in serum and leukocytes.
Cystic Fibrosis
Abnormal distribution of alpha-L-fucosidase in cystic fibrosis: decreased activity in serum.
Abnormal distribution of alpha-L-fucosidase in cystic fibrosis: increased activity in skin fibroblasts.
alpha-L-Fucosidase in cystic fibrosis.
alpha-L-Fucosidase in cystic fibrosis: analysis of skin fibroblasts and liver.
alpha-L-Fucosidase is quantitatively reduced in cultured lymphoblasts from patients with cystic fibrosis.
Altered isoenzyme patterns of liver alpha-L-fucosidase in cystic fibrosis.
Are measurements of urine enzymes useful during aminoglycoside therapy?
Cobalamin R binder as a possible model molecule for glycoprotein study in cystic fibrosis.
Cystic fibrosis serum alpha-l-fucosidase: confirmation of normal activity levels and normal kinetic and isoelectric focusing properties.
Differential concanavalin A binding of cystic fibrosis and normal liver alpha-L-fucosidase.
Primary amniotic fluid cell, skin fibroblast and liver alpha-L-fucosidase and its relation to cystic fibrosis.
Purification and characterization of altered cystic fibrosis liver alpha-L-fucosidase.
Susceptibility to neuraminidase of alpha-L-fucosidase and N-acetyl-beta-D-glucosaminidase of cystic fibrosis, I-cell and neuraminidase-deficient fibroblasts.
Urinary alpha-L-fucosidase in cystic fibrosis.
Dental Plaque
alpha-L-Fucosidase activity in human saliva and dental plaque.
Dermatitis, Atopic
Increased leukotriene B(4) production, complement C3 conversion and acid hydrolase enzyme concentrations in different leucocyte sub-populations of dogs with atopic dermatitis.
Diabetes Complications
Alterations of glycosaminoglycan metabolism in the development of diabetic complications in relation to metabolic control.
Diabetes Mellitus
Alterations in the activity of several glycohydrolases in red blood cell membrane from type 2 diabetes mellitus patients.
Alterations of glycosaminoglycan metabolism in the development of diabetic complications in relation to metabolic control.
Decreased serum beta-D-mannosidase activity in diabetic patients, in comparison with other glycosidases.
Effect of diabetes mellitus on selected acid hydrolase activities in human platelets.
Diabetes Mellitus, Type 2
Alterations in the activity of several glycohydrolases in red blood cell membrane from type 2 diabetes mellitus patients.
Alterations of glycosaminoglycan metabolism in the development of diabetic complications in relation to metabolic control.
Dysostoses
Fucosidosis type 2.
Dystonia
A Novel Homozygous Mutation in the FUCA1 Gene Highlighting Fucosidosis as a Cause of Dystonia: Case Report and Literature Review.
Endometrial Neoplasms
Fucosyltransferase and alpha-L-fucosidase activities and fucose levels in normal and malignant endometrial tissue.
Epilepsy
Targeting the endocannabinoid system in the amygdala kindling model of temporal lobe epilepsy in mice.
Epilepsy, Temporal Lobe
Targeting the endocannabinoid system in the amygdala kindling model of temporal lobe epilepsy in mice.
Esophageal Squamous Cell Carcinoma
Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma.
exo-alpha-sialidase deficiency
Biochemical comparison of the dysmorphic type with the normosomatic type of sialidosis.
Fabry Disease
Angiocheratoma corporis diffusum with normal enzyme activities.
Change of isoforms' spectra of alpha-L-fucosidase from human skin fibroblasts in intracellular storage of nonhydrolyzable substances.
Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patients.
Fucosidosis.
Non-viral, integrin-mediated gene transfer into fibroblasts from patients with lysosomal storage diseases.
[Change of isoforms' spectrum of alpha-L-fucoside secreted by affected cells in some hereditary lysosomal diseases]
Fucosidosis
A 5' splice site mutation in fucosidosis.
A 66-basepair insertion in exon 6 of the alpha-L-fucosidase gene of a fucosidosis patient.
A case of chronic infantile type of fucosidosis: clinical and magnetic resonance image findings.
A missense mutation (S63L) in alpha-L-fucosidase is responsible for fucosidosis in an Italian patient.
A mutation generating a stop codon in the alpha-L-fucosidase gene of a fucosidosis patient.
A novel FUCA1 mutation causing fucosidosis in a Chinese boy.
A Novel Homozygous Mutation in the FUCA1 Gene Highlighting Fucosidosis as a Cause of Dystonia: Case Report and Literature Review.
Abnormal expression of alpha-L-fucosidase in lymphoid cell lines of fucosidosis patients.
Absence of alpha-fucosidase activity in two sisters showing a different phenotype.
Activity and multiple forms of alpha-L-fucosidase and hexosaminidase in chorion biopsy specimens and some fetal organs.
Alpha-L-fucosidase and alpha-D-mannosidase activity in the white blood cells in the disease and carrier state of fucosidosis.
Alpha-L-fucosidase in cultured bone marrow fibroblasts from fucosidosis patients.
alpha-L-fucosidase in cultured skin fibroblasts from normal subjects and fucosidosis patients.
alpha-L-Fucosidase in normal and deficient individuals.
Alpha-L-fucosidases: exoglycosidases with unusual transglycosylation properties.
Amelioration of clinical disease following bone marrow transplantation in fucosidase-deficient dogs.
Biochemical and genetic studies of plasma and leukocyte alpha-L-fucosidase.
Biochemical and immunological characterization of a glycosylated alpha-fucosidase from the invertebrate Unio: interaction of the enzyme with its in vivo binding partners.
Biosynthesis, processing, and extracellular release of alpha-L-fucosidase in lymphoid cell lines of different genetic origins.
Canine alpha-L-fucosidase in relation to the enzymic defect and storage products in canine fucosidosis.
Canine fucosidosis: a biochemical and genetic investigation.
Characterization and 400-MHz 1H-NMR analysis of urinary fucosyl glycoasparagines in fucosidosis.
Characterization of alpha-L-fucosidase from two different families with fucosidosis.
Characterization of EcoRI mutation in fucosidosis patients: a stop codon in the open reading frame.
Correction of alpha-L-fucosidase deficiency in fucosidosis fibroblasts by retroviral vector-mediated gene transfer.
Crystal structure of Thermotoga maritima alpha-L-fucosidase. Insights into the catalytic mechanism and the molecular basis for fucosidosis.
Defective expression of alpha-L-fucosidase by lymphoid cells of a fucosidosis patient.
Deficiency of fucosidase results in acrosomal dysgenesis and impaired sperm maturation.
Detection of carriers and prenatal diagnosis for fucosidosis in Calabria.
Determination of lysosomal enzymes in saliva. Confirmation of the diagnosis of metachromatic leukodystrophy and fucosidosis by enzyme analysis.
Diagnosis and Supportive Management of Fucosidosis: A Case Report.
Electrophoretic forms of human liver alpha-L-fucosidase and their relationship to fucosidosis (mucopolysaccharidosis F).
Fucosidosis in a native-born Briton.
Fucosidosis in Tunisian patients: mutational analysis and homology-based modeling of FUCA1 enzyme.
Fucosidosis revisited: a review of 77 patients.
Fucosidosis type 2.
Fucosidosis with angiokeratoma. Immunohistochemical & electronmicroscopic study of a new case and literature review.
Fucosidosis with hypothyroidism: a case report.
Fucosidosis with Pathogenic Variant in FUCA1 Gene.
Fucosidosis-Clinical Manifestation, Long-Term Outcomes, and Genetic Profile-Review and Case Series.
Fucosidosis: deficiency of alpha-L-fucosidase in cultured skin fibroblasts.
Fucosidosis: four new mutations and a new polymorphism.
Fucosidosis: genetic and biochemical analysis of eight cases.
Heterogeneity of mRNA expression in Italian fucosidosis patients.
Histology and electron microscopy of fucosidosis of the skin. Subtle clues to diagnosis by electron microscopy.
Human alpha-L-fucosidase: complete coding sequence from cDNA clones.
Identification of a mutation in the structural alpha-L-fucosidase gene in fucosidosis.
Identification of a novel homozygous loss-of-function mutation in FUCA1 gene causing severe fucosidosis: A case report.
Isolation of the canine alpha-L-fucosidase cDNA and definition of the fucosidosis mutation in English Springer Spaniels.
Metabolic correction of fucosidosis fibroblasts by human alpha-L-fucosidase.
Molecular biology of the alpha-L-fucosidase gene and fucosidosis.
Molecular cloning of a cDNA for human alpha-L-fucosidase.
Molecular defect in processing alpha-fucosidase in fucosidosis.
MRI and MRS findings in fucosidosis; a rare lysosomal storage disease.
Mutation analysis of a Japanese patient with fucosidosis.
Mutations in fucosidosis gene: a review.
Non-viral, integrin-mediated gene transfer into fibroblasts from patients with lysosomal storage diseases.
Normal alpha-L-fucosidase and other lysosomal enzyme activities in progressive cone dystrophy.
Novel mutations in the FUCA1 gene that cause fucosidosis.
Pedigree analysis of alpha-L-fucosidase gene mutations in a fucosidosis family.
Phenotypic spectrum of fucosidosis in Tunisia.
Plasma alpha-L-fucosidase activity in chronic inflammation and autoimmune disorders in a pediatric cohort of hospitalized patients.
Purification and characterization of alpha-L-fucosidase from the liver of a fucosidosis patient.
Purification and serological studies of human alpha-L-fucosidase in the normal and fucosidosis states.
Radioimmunoassay determination of decreased amounts of alpha-L-fucosidase protein in fucosidosis.
Recalcitrant chronic rhinosinusitis in the setting of fucosidosis, a rare lysosomal storage disorder.
Recurrent respiratory infections in a child with fucosidosis: is the mucus too thin for effective transport?
Relationship between alpha-L-fucosidase deficiency in plasma and alpha-L-fucosidase activity in leukocytes.
Restriction analysis of the structural alpha-L-fucosidase gene and its linkage to fucosidosis.
Six additional mutations in fucosidosis: three nonsense mutations and three frameshift mutations.
Specific activity of alpha-L-fucosidase in sera with phenotypes of either low, intermediate, or high total enzyme activity and in a fucosidosis serum.
Spectrum of mutations in fucosidosis.
Structure and sequence of the human alpha-L-fucosidase gene and pseudogene.
The Identification of a Novel Fucosidosis-Associated FUCA1 Mutation: A Case of a 5-Year-Old Polish Girl with Two Additional Rare Chromosomal Aberrations and Affected DNA Methylation Patterns.
Therapy Development for the Lysosomal Storage Disease Fucosidosis using the Canine Animal Model.
Thermostability of human alpha-L-fucosidase. Relationship to fucosidosis and low-activity serum alpha-L-fucosidase.
Transcriptomic analysis of FUCA1 knockdown in keratinocytes reveals new insights in the pathogenesis of fucosidosis skin lesions.
Two different families with alpha-L-fucosidase deficiency.
Two patients with an unusual form of type II fucosidosis.
[Angiokeratoma and fucosidosis. Immunohistochemical and ultrastructural study]
Gangliosidosis, GM1
Transient high-level expression of beta-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA.
Gaucher Disease
Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant.
Infantile Gaucher's disease: neuropathology, acid hydrolase activities and negative staining observations.
Tissue acid hydrolase activities in Gaucher's disease.
Genetic Diseases, Inborn
Mammalian alpha-L-fucosidases.
[Angiokeratoma and fucosidosis. Immunohistochemical and ultrastructural study]
Glioblastoma
Downregulation of ?-l-fucosidase 1 suppresses glioma progression by enhancing autophagy and inhibiting macrophage infiltration.
Glioma
Downregulation of ?-l-fucosidase 1 suppresses glioma progression by enhancing autophagy and inhibiting macrophage infiltration.
Glycogen Storage Disease
A microfluorometric assay of leukocyte alpha-1,4-glucosidase.
Glycogen Storage Disease Type II
A microfluorometric assay of leukocyte alpha-1,4-glucosidase.
Granuloma
Acid hydrolase activity in the resorbing carrageenan granuloma.
Graves Disease
Serum lysosomal acid hydrolase activities in Graves' disease.
Hemochromatosis
[A study of lysosomal enzyme activities in serum and leukocytes in chronic hepatic disease (author's transl)]
Hepatitis
Activities of serum enzymes in patients with viral hepatitis B, posthepatitic cirrhosis and hepatocellular carcinoma.
Cyclooxygenase-2 single-nucleotide polymorphisms and hepatocellular carcinoma in Egypt.
Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
Serum beta-N-acetylglucosaminidase, beta-D-glucosidase, alpha-D-glucosidase, beta-D-fucosidase, alpha-L-fucosidase and beta-D-galactosidase levels in acute viral hepatitis, pancreatitis, myocardial infarction and breast cancer.
[A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma]
Hepatitis B
Activities of serum enzymes in patients with viral hepatitis B, posthepatitic cirrhosis and hepatocellular carcinoma.
Hepatitis C
Serum midkine is a more sensitive predictor for hepatocellular carcinoma than Dickkopf-1 and alpha-L-fucosidase in cirrhotic HCV patients.
Hepatitis, Chronic
Activities of serum enzymes in patients with viral hepatitis B, posthepatitic cirrhosis and hepatocellular carcinoma.
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
[A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma]
Herpes Zoster
Hamster Sperm-Associated Alpha-L-Fucosidase Functions During Fertilization.
Hyperinsulinism
Effect of hyperinsulinemia on acid cholesterol ester hydrolase activity in liver, heart and epididymal fat pad preparations from rats and mice.
Hyperthyroidism
Serum lysosomal acid hydrolase activities in Graves' disease.
Hypoproteinemia
Effects of maternal protein deprivation on the nutritional status and neutrophil function of suckling neonatal rats.
Infections
Activities of serum enzymes in patients with viral hepatitis B, posthepatitic cirrhosis and hepatocellular carcinoma.
Correction of alpha-L-fucosidase deficiency in fucosidosis fibroblasts by retroviral vector-mediated gene transfer.
Hepatic acid hydrolases of albino rats, Mastomys natalensis and albino mice during Plasmodium berghei infection.
Muscovy duck reovirus promotes virus replication by inhibiting autophagy-lysosomal degradation pathway.
Infertility
Hamster Sperm-Associated Alpha-L-Fucosidase Functions During Fertilization.
On some glycosidases (beta-D-mannosidase, alpha-L-fucosidase, N-acetyl-beta-D-glucosaminidase) of human seminal plasma.
Inflammatory Bowel Diseases
The role of fatty acid hydrolase gene variants in inflammatory bowel disease.
Influenza, Human
[Role of carbohydrates in the manifestation of the hemagglutinating and neuraminidase activities of the influenza virus]
Intestinal Obstruction
[The state of the erythrocyte membrane and acid hydrolase activity in mechanical intestinal obstruction]
Iron Overload
Acid hydrolase activities and lysosomal integrity in liver biopsies from patients with iron overload.
Leukemia
alpha-L-fucosidase and beta-hexosaminidase isoenzymes in human leukemia.
[Alpha-L-fucosidase of normal and pathological blood cells]
Leukemia, Lymphocytic, Chronic, B-Cell
alpha-L-Fucosidase activity and isoenzyme characteristics analyzed by chromatofocusing in normal and leukemic lymphocytes.
Leukemia, Myeloid, Acute
Patterns of alpha-L-fucosidase in acute myeloid leukemia cells. Comparison with promyelocytic HL-60 cell line.
Leukodystrophy, Globoid Cell
Krabbe disease: New hope for an old disease.
Leukodystrophy, Metachromatic
Determination of lysosomal enzymes in saliva. Confirmation of the diagnosis of metachromatic leukodystrophy and fucosidosis by enzyme analysis.
Liver Cirrhosis
Prediction of the development of hepato-cellular-carcinoma in patients with liver cirrhosis by the serial determinations of serum alpha-L-fucosidase activity.
Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
Serum midkine is a more sensitive predictor for hepatocellular carcinoma than Dickkopf-1 and alpha-L-fucosidase in cirrhotic HCV patients.
[Value of the serum measurement of alpha-L-fucosidase in the diagnosis of hepatocarcinoma]
Liver Cirrhosis, Alcoholic
[A study of lysosomal enzyme activities in serum and leukocytes in chronic hepatic disease (author's transl)]
Liver Diseases
Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
[A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma]
[A study of lysosomal enzyme activities in serum and leukocytes in chronic hepatic disease (author's transl)]
[Diagnostic significance of the determination of serum alpha-L-fucosidase in primary hepatocellular carcinoma]
[Value of serum glycosidase spectrum in the diagnosis of hepatocellular carcinoma]
Liver Neoplasms
Purification and characterization of alpha-L-fucosidase from human primary hepatocarcinoma tissue.
[A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma]
[The value of serum alpha-L-fucosidase activity in the diagnosis of primary liver cancer]
Lysosomal Storage Diseases
A 5' splice site mutation in fucosidosis.
A mutation generating a stop codon in the alpha-L-fucosidase gene of a fucosidosis patient.
Abnormal expression of alpha-L-fucosidase in lymphoid cell lines of fucosidosis patients.
Alpha-L-fucosidases: exoglycosidases with unusual transglycosylation properties.
Canine alpha-L-fucosidase in relation to the enzymic defect and storage products in canine fucosidosis.
Cell-autonomous expression of the acid hydrolase galactocerebrosidase.
Chronic enzyme replacement therapy ameliorates neuropathology in alpha-mannosidosis mice.
Defective expression of alpha-L-fucosidase by lymphoid cells of a fucosidosis patient.
Diagnosis and Supportive Management of Fucosidosis: A Case Report.
First trimester prenatal diagnosis of lysosomal storage disease. Study of alpha-L-fucosidase isoenzyme patterns in fetal and maternal tissue.
Fucosidosis in Tunisian patients: mutational analysis and homology-based modeling of FUCA1 enzyme.
Fucosidosis with angiokeratoma. Immunohistochemical & electronmicroscopic study of a new case and literature review.
Fucosidosis: four new mutations and a new polymorphism.
Fucosidosis: genetic and biochemical analysis of eight cases.
Genetic heterogeneity of I-cell disease is demonstrated by complementation of lysosomal enzyme processing mutants.
Pedigree analysis of alpha-L-fucosidase gene mutations in a fucosidosis family.
Six additional mutations in fucosidosis: three nonsense mutations and three frameshift mutations.
Structure and sequence of the human alpha-L-fucosidase gene and pseudogene.
Therapy Development for the Lysosomal Storage Disease Fucosidosis using the Canine Animal Model.
Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse.
[Screening methods for the diagnosis of lysosomal storage disease]
Macular Degeneration
Progressive cone dystrophy associated with low alpha-L-fucosidase activity in serum and leukocytes.
Massive Hepatic Necrosis
Activities of serum enzymes in patients with viral hepatitis B, posthepatitic cirrhosis and hepatocellular carcinoma.
[A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma]
Melanoma
Reduction of metastatic properties of BL6 melanoma cells expressing terminal fucose(alpha)1-2-galactose after alpha1,2-fucosyltransferase cDNA transfection.
Metabolic Diseases
Structure of human saposin A at lysosomal pH.
The value of anti-rods and rings antibodies in patients with nonhepatitis virus infection: A single-center retrospective study from Southwest China.
Metabolism, Inborn Errors
[Screening methods for the diagnosis of lysosomal storage disease]
Metrorrhagia
Endometrial lysosomal enzyme activity in ovulatory dysfunctional uterine bleeding, IUCD users and post-partum women.
Mouth Neoplasms
Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
Mucolipidoses
Acid hydrolase deficiencies and abnormal glycoproteins in mucolipidosis. 3 (pseudo-Hurler polydystrophy).
Biosynthesis, processing, and secretion of alpha-L-fucosidase in lymphoid cells from patients with I-cell disease and pseudo-Hurler polydystrophy.
Elevated cystine levels in cultured skin fibroblasts from patients with I-cell disease.
Genetic heterogeneity of I-cell disease is demonstrated by complementation of lysosomal enzyme processing mutants.
Homozygosity for the variant alpha-L-fucosidase trait and mucolipidosis III.
I-cell disease (mucolipidosis II): resolution of N-acetyl-beta-D-glucosaminidase and alpha-L-fucosidase components by DEAE-cellulose chromatography.
Mucolipidosis III: two patients displaying genetic pleiotropism.
Phosphorylation and subcellular location of alpha-L-fucosidase in lymphoid cells from patients with I-cell disease and pseudo-Hurler polydystrophy.
Postendocytic maturation of acid hydrolases: evidence of prelysosomal processing.
Purification and characterization of I-cell disease alpha-L-fucosidase.
The DMAP interaction domain of UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase is a substrate recognition module.
Urinary lysosomal hydrolases in mucolipidosis II and mucolipidosis III.
Mucopolysaccharidoses
Cloning of the canine beta-glucuronidase cDNA, mutation identification in canine MPS VII, and retroviral vector-mediated correction of MPS VII cells.
Inner ear pathology in the mucopolysaccharidosis VII mouse.
Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse.
Mucopolysaccharidosis VII
Cloning of the canine beta-glucuronidase cDNA, mutation identification in canine MPS VII, and retroviral vector-mediated correction of MPS VII cells.
Inner ear pathology in the mucopolysaccharidosis VII mouse.
Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse.
Muscular Dystrophies
[Possible participation of cyclic AMP in regulating acid hydrolase activity in muscle tissue in avitaminosis E and denervation]
Myocardial Infarction
Serum beta-N-acetylglucosaminidase, beta-D-glucosidase, alpha-D-glucosidase, beta-D-fucosidase, alpha-L-fucosidase and beta-D-galactosidase levels in acute viral hepatitis, pancreatitis, myocardial infarction and breast cancer.
[1 of the possible causes of an increase in acid hydrolase activity in homogenates of heart muscle following myocardial infarct]
Myocardial Ischemia
[Acid hydrolase activity and cyclic nucleotide contents in the rat heart during myocardial ischemia and postischemic reperfusion]
Myopia
Progressive cone dystrophy associated with low alpha-L-fucosidase activity in serum and leukocytes.
Nematode Infections
Comparative development of Brugia pahangi and variation in acid hydrolase enzyme titers in.
Neoplasm Metastasis
Alpha-L-fucosidases: exoglycosidases with unusual transglycosylation properties.
Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Down-regulation of ?-L-fucosidase 1 expression confers inferior survival for triple-negative breast cancer patients by modulating the glycosylation status of the tumor cell surface.
Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer.
Neoplasms
A novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cells.
Acid hydrolase and cytochrome oxidase activities in nitrosourea induced tumors of the nervous system.
Activity and properties of alpha-L-fucosidase are dependent on the state of enterocytic differentiation of HT-29 colon cancer cells.
alpha-L-fucosidase activity in endometrial, cervical and ovarian cancer.
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks.
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
Alpha-L-fucosidase as a tumour marker of hepatocellular carcinoma.
Alpha-L-fucosidase enzyme in the prediction of colorectal cancer patients at high risk of tumor recurrence.
Alpha-L-Fucosidase Serves as a Prognostic Indicator for Intrahepatic Cholangiocarcinoma and Inhibits Its Invasion Capacity.
alpha-L-fucosidase variant and lipid-associated sialic acid in hereditary ovarian cancer.
Alpha-L-fucosidase-1 is a diagnostic marker that distinguishes mucoepidermoid carcinoma from squamous cell carcinoma.
Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma.
Alteration in glycosidases from well-differentiated colorectal adenocarcinoma of rat.
Alterations in human breast cancer adhesion-motility in response to changes in cell surface glycoproteins displaying alpha-L-fucose moieties.
Clinical interest of the combined use of serum CD26 and alpha-L-fucosidase in the early diagnosis of colorectal cancer.
Combined use of established and novel tumour markers in the diagnosis of head and neck squamous cell carcinoma.
Decreased Expression of Alpha-L-Fucosidase Gene FUCA1 in Human Colorectal Tumors.
Diagnostic value of alpha-L-fucosidase for hepatocellular carcinoma: a meta-analysis.
Dietary and demographic correlates of serum beta-glucuronidase activity.
Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Down-regulation of ?-L-fucosidase 1 expression confers inferior survival for triple-negative breast cancer patients by modulating the glycosylation status of the tumor cell surface.
Downregulation of ?-l-fucosidase 1 suppresses glioma progression by enhancing autophagy and inhibiting macrophage infiltration.
Early prediction of liver carcinogenicity due to occupational exposure to pesticides.
Effect of occupational exposure to aflatoxins on some liver tumor markers in textile workers.
Elevated activity of cytidine 5'-monophospho-N-acetylneuraminic acid hydrolase in serum of ovarian cancer patients as a possible indicator of malignancy.
Elevation of acid glycosidase activities in thyroid and gastric tumors.
Enzymorphological observation on irradiated tumor, with a particular reference to acid hydrolase activity. I. Light microscopic study.
FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status.
Fucosyltransferase and alpha-L-fucosidase activities and fucose levels in normal and malignant endometrial tissue.
Glycosyltransferase and glycosidase activities in ovarian cancer patients.
Isoelectric focusing of alpha-L-fucosidase from human embryonal carcinoma.
Isoelectric forms of alpha-L-fucosidase in mouse teratocarcinoma-derived cell lines.
Low levels of alpha-L-fucosidase activity in colorectal cancer are due to decreased amounts of the enzymatic protein and are related with Dukes' stage.
p53 directly regulates the glycosidase FUCA1 to promote chemotherapy-induced cell death.
Phorbol 12-myristate 13-acetate-induced ectodomain shedding and phosphorylation of the human meprinbeta metalloprotease.
Plasma alpha-L-fucosidase activity and the risk of borderline epithelial ovarian tumors.
Preoperative AFU Is a Useful Serological Prognostic Predictor for Colorectal Liver Oligometastasis Patients Undergoing Hepatic Resection.
Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer.
Presence of fucosyl residues on the oligosaccharide antennae of membrane glycopeptides of human neuroblastoma cells.
Purification and characterization of alpha-L-fucosidase from human primary hepatocarcinoma tissue.
Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Serum alpha L-fucosidase enzyme activity in ovarian and other female genital tract tumors.
Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
Serum alpha-L-fucosidase. A useful marker in the diagnosis of hepatocellular carcinoma.
Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma.
Serum tumor markers for detection of hepatocellular carcinoma.
Specificity of macrophage-mediated cytotoxicity: role of target and effector cell fucose.
Studies on the kinetics of glycosidases from chemically-induced rat colonic tumours and normal rat colon.
The Value of Preoperative Alpha-L-Fucosidase Levels in Evaluation of Malignancy and Differential Diagnosis of Urothelial Neoplasms.
Tumour-associated antigens for cystadenocarcinoma of the ovary.
Value of the serum alpha-L-fucosidase activity in the diagnosis of colorectal cancer.
Zinc oxide nanoparticles as a novel anticancer approach; in vitro and in vivo evidence.
[A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma]
Nervous System Neoplasms
Acid hydrolase and cytochrome oxidase activities in nitrosourea induced tumors of the nervous system.
Neurologic Manifestations
Fucosidosis type 2.
Non-alcoholic Fatty Liver Disease
Association between serum ?-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.
Obesity
The fatty acid amide hydrolase (FAAH) Pro129Thr polymorphism is not associated with severe obesity in Greek subjects.
Ovarian Cysts
Changes of serological activity by alpha-L-fucosidase isolated from Streptococcus sanguis ATCC 10557.
Ovarian Neoplasms
alpha-L-fucosidase activity in endometrial, cervical and ovarian cancer.
alpha-L-fucosidase variant and lipid-associated sialic acid in hereditary ovarian cancer.
Elevated activity of cytidine 5'-monophospho-N-acetylneuraminic acid hydrolase in serum of ovarian cancer patients as a possible indicator of malignancy.
Frequency of an allele for low activity of alpha-L-fucosidase in sera: possible increase in epithelial ovarian cancer patients.
Genetic epidemiology of epithelial ovarian cancer.
Tumor markers for ovarian cancer.
Tumour-associated antigens for cystadenocarcinoma of the ovary.
Pancreatitis
Serum beta-N-acetylglucosaminidase, beta-D-glucosidase, alpha-D-glucosidase, beta-D-fucosidase, alpha-L-fucosidase and beta-D-galactosidase levels in acute viral hepatitis, pancreatitis, myocardial infarction and breast cancer.
Parkinson Disease
Altered regulation of serum lysosomal acid hydrolase activities in Parkinson's disease: A potential peripheral biomarker?
Parkinsonian Disorders
Altered regulation of serum lysosomal acid hydrolase activities in Parkinson's disease: A potential peripheral biomarker?
Pemphigus
The Value of Serum B Glucuronidase Estimation in Assessing the Response to the Therapy For Pemphigus.
Peptic Ulcer
Lysosomal acid hydrolase alterations in gastric mucosa from an experimental peptic ulcer model.
Periodontitis
Glycosidase activities in gingival crevicular fluid in subjects with adult periodontitis or gingivitis.
Persistent Infection
Semen sialic acid surge and modulation of alpha-L-fucosidase activity: possible link to loss in reproductive capacity during trypanosomiasis.
Photosensitivity Disorders
[Photosensitization and lysosomal acid hydrolase in the nervous tissue]
Pleural Effusion, Malignant
Serum and pleural fluid levels of alpha-L-fucosidase and sialic acid have no diagnostic value in malignant pleural effusions.
Pleurisy
Serum and pleural fluid levels of alpha-L-fucosidase and sialic acid have no diagnostic value in malignant pleural effusions.
Precancerous Conditions
Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
alpha-L-Fucosidase activity and isoenzyme characteristics analyzed by chromatofocusing in normal and leukemic lymphocytes.
Psoriasis
The effect of PUVA treatment on acid hydrolases in human polymorphonuclear leukocytes.
Retinal Detachment
Progressive cone dystrophy associated with low alpha-L-fucosidase activity in serum and leukocytes.
Retinal Dystrophies
Localization of lysosomal enzymes in retinal pigment epithelium of rats with inherited retinal dystrophy.
Sandhoff Disease
Activity and multiple forms of alpha-L-fucosidase and hexosaminidase in chorion biopsy specimens and some fetal organs.
Sarcoma
A genetic map of nine loci on bovine chromosome 2.
Sarcoma, Experimental
Acid hydrolase activity during the growth, necrosis, and regression of the Jensen sarcoma.
Seminoma
Isoelectric focusing of alpha-L-fucosidase from human embryonal carcinoma.
Squamous Cell Carcinoma of Head and Neck
A Meta-Analysis: Identification of Common Mir-145 Target Genes that have Similar Behavior in Different GEO Datasets.
Alpha-L-fucosidase-1 is a diagnostic marker that distinguishes mucoepidermoid carcinoma from squamous cell carcinoma.
Combined use of established and novel tumour markers in the diagnosis of head and neck squamous cell carcinoma.
Starvation
Increased acid hydrolase activity during carbon starvation in Euglena gracilis.
Stomach Neoplasms
Increased serum alpha-L-fucosidase and beta-N-acetylglucosaminidase activities in diabetic, cirrhotic and gastric cancer patients.
Role for alpha-L-fucosidase in the control of Helicobacter pylori-infected gastric cancer cells.
Stomach Ulcer
[Glycoprotein metabolism and gastric ulcer: an experimental study with special reference to alpha-L-fucosidase activity and gastric ulcer (author's transl)]
Teratocarcinoma
Isoelectric forms of alpha-L-fucosidase in mouse teratocarcinoma-derived cell lines.
Tetanus
A genetic fusion construct between the tetanus toxin C fragment and the lysosomal acid hydrolase beta-glucuronidase expresses a bifunctional protein with enhanced secretion and neuronal uptake.
Thyroid Cancer, Papillary
FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status.
[Corrigendum] FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status.
Thyroid Carcinoma, Anaplastic
FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status.
[Corrigendum] FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status.
Thyroid Neoplasms
FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status.
[Corrigendum] FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status.
Triple Negative Breast Neoplasms
Down-regulation of ?-L-fucosidase 1 expression confers inferior survival for triple-negative breast cancer patients by modulating the glycosylation status of the tumor cell surface.
Trypanosomiasis
Semen sialic acid surge and modulation of alpha-L-fucosidase activity: possible link to loss in reproductive capacity during trypanosomiasis.
Urinary Bladder Neoplasms
A Meta-Analysis: Identification of Common Mir-145 Target Genes that have Similar Behavior in Different GEO Datasets.
Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.
Vitamin B 6 Deficiency
Increased lysosomal hydrolase activity in kidney and brain from the vitamin B6-deficient developing rat.
Wolman Disease
[Hepatic cholesterolosis. Histological, histochemical and ultrastructural study of 2 cases]